National Dentex Labs (NDX), the leading full-service dental laboratory partner in North America, today announced that Kevin Mosher has officially become the company’s Chief Executive Officer.
Mr. Mosher has been a member of the NDX Board of Directors since 2023 and was promoted to Executive Chairman in May of this year. He has more than 25 years of extensive dental industry experience.
Prior to joining NDX, Mosher served as CEO and Executive Chairman of ClearChoice Dental Implant Centers, successfully developing the company into a US market leader with more than 90 implant centers covering 34 states.
In addition, earlier in his career, he served as President of Dental Implant Manufacturing North America for Nobel Biocare.
As CEO, Mosher will focus on integrating NDX’s strong network resources, professional experience and customer service advantages to build lasting and strong customer relationships.
He plans to work with the management team to expand the company’s capabilities and product lines through strategic investments, deepen partnerships, and seize continued growth opportunities to further consolidate NDX’s leading position in the industry.
Mosher said: “NDX has a unique competitive advantage with its leading national network of advanced laboratories and excellent service platform. In the past year, I have witnessed the passion and strength of the team and the huge growth potential.
I am honored to lead the company full-time and work with the talented team to provide customers with high-quality products and services at the highest standards.”
Craig Brooks, a member of the NDX Board of Directors, also highly praised Mr. Mosher’s leadership: “Kevin is a well-respected leader in the dental field with outstanding business and operational achievements.
He has made a positive impact on the company during his time as a member of the Board of Directors, and we are confident in the future of NDX under his leadership.”